Tokyo, Feb 27, 2006 (JCN) - Bayer Yakuhin announced on February 24 that it has obtained additional approval for Ciproxan Injection/Tablet, its proprietary new-quinolone agent, from the Ministry of Health, Labor and Welfare. Ciproxan is now available in the treatment of infections caused by Legionella bacteria including Legionella pneumonia.
